Mauro, Daniele http://orcid.org/0000-0002-9022-8863
Forte, Giulio http://orcid.org/0009-0000-6218-9185
Poddubnyy, Denis http://orcid.org/0000-0002-4537-6015
Ciccia, Francesco http://orcid.org/0000-0002-9352-1264
Article History
Received: 15 September 2023
Accepted: 8 November 2023
First Online: 18 December 2023
Declarations
:
: Denis Poddubnyy: Research support from AbbVie, Eli Lilly, MSD, Novartis, Pfizer; Consulting fees from AbbVie, Biocad, Bristol-Myers Squibb, Eli Lilly, Janssen, Moonlake, Novartis, Pfizer, and UCB; Speaker fees from AbbVie, Canon, DKSH, Eli Lilly, Janssen, MSD, Medscape, Novartis, Peervoice, Pfizer, and UCB; Member of the executive committee of ASAS; Member of steering committee of GRAPPA. Francesco Ciccia: Research support from AbbVie, Eli Lilly, Novartis, Pfizer; Consulting and speaking fees from AbbVie, Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, Galapagos, Janssen, Novartis, Pfizer, and UCB; Full member of ASAS. Daniele Mauro and Guilio Forte have nothing to disclose.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.